6-Methoxypurine-9-beta-D- (3-methoxy riboside)

6-Methoxypurine-9-beta-D- (3-methoxy riboside) is a purine nucleoside analog with broad antitumor activity, notably against indolent lymphoid cancers. Its mechanisms involve inhibiting DNA synthesis and inducing apoptosis, as demonstrated in both in vitro and in vivo experimental models for oncology research.